DPIIT recognised startup Government of India
Startup India
Wuze Pharmaceuticals Private Limited - e-commerce in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2026
₹18.8 Cr
▲ 385% YoY
Net profit · FY 2026
₹19.08 Lakh
Net margin 1%
EBITDA · FY 2026
₹32.27 Lakh
EBITDA margin 1.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Wuze Pharmaceuticals Private Limited
Data last updated:
Wuze Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the online healthcare product retail segment of the e-commerce sector. It was incorporated on 24 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC328905. Its GSTIN is 07AACCW1411E1ZV (Delhi).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Mansi Aggarwal and Praveen Kumar Singla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Shop No 4 Ground Floor Wegmans Prinston Plaza Blk – H Csc Sector 18, Rohini City, Delhi, India – 110089.
As per the financials filed for FY 2026, the company reported a revenue of ₹18.8 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹19.08 Lakh (net margin 1%) and EBITDA of ₹32.27 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 274% over three years and 126% over five years.
Wuze Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0003843). For more details, the company can be reached via its website wuzeinternational.com.
Company details
CIN U74999DL2018PTC328905
Registration Number 328905
Incorporation Date 24 January 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-DL-06-0003843
Recognitions & Rankings of Wuze Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2026-27)
- Udyam number
- UDYAM-DL-06-0003843
Contact details
Wuze Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is wuzeinternational.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No 4 Ground Floor Wegmans Prinston Plaza Blk – H Csc Sector 18, Rohini City, Delhi, India – 110089
- IndustryE-Commerce, Online Healthcare Product Retail
To see the full contact details of Wuze Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Wuze Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wuze Pharmaceuticals is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Wuze Pharmaceuticals Private Limited, buy the company report.
Financials of Wuze Pharmaceuticals Private Limited
FY 2026 filings availableWuze Pharmaceuticals Private Limited reported revenue of ₹18.8 Cr (up 385% YoY) for FY 2026.
Revenue · FY 2026
₹18.8 Cr ▲ 385%
Net profit · FY 2026
₹19.08 Lakh margin 1%
EBITDA · FY 2026
₹32.27 Lakh margin 1.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 385%
3 years · compounded
▲ 274%
5 years · compounded
▲ 126%
EBITDA CAGR growth
1 year
▲ 258%
3 years · compounded
▲ 405%
5 years · compounded
▲ 2%
Revenue has grown at a compounded annual rate (CAGR) of 126% over five years, including 385% growth in the latest year. EBITDA rose 258% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹18.8 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹32.27 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹19.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wuze Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wuze Pharmaceuticals Private Limited
Wuze Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mansi Aggarwal | Director | 01 Aug 2022 | 4 Years 3 Months | Current |
| Praveen Kumar Singla Also directs: Wuze Ayurveda Private Limited, Wuze International Private Limited | Director | 24 Jan 2018 | 8 Years 9 Months | Current |
Auditor
Wuze Pharmaceuticals Private Limited is audited by Subhash Chandra Agarwal for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Subhash Chandra Agarwal | FY 2026 | 089228 |
Shareholding
The shareholding of Wuze Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wuze Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wuze Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wuze Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wuze Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCW1411E1ZV | Delhi | Active | 20 Feb 2018 |
To see the full GST registrations and return filing status of Wuze Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wuze Pharmaceuticals Private Limited has 5 board changes on record since 2018: 2 appointments and 3 cessations. The latest: Mansi Aggarwal ceased to be Additional Director on 29 Sep 2022.
Filing
Wuze Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi Ii.
AGM
Wuze Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Mansi Aggarwal ceased to be Additional Director.
Appointed
Mansi Aggarwal was appointed as Director.
Ceased
Sanchit Gupta ceased to be Additional Director.
Ceased
Manoj Sharma ceased to be Director.
Appointed
Praveen Kumar Singla was appointed as Director.
Incorporation
24 Jan 2018
Wuze Pharmaceuticals Private Limited was registered on 24 Jan 2018 with Roc Delhi Ii & aged 8 years 9 months as per MCA records.
Frequently asked questions
Wuze Pharmaceuticals is an active private limited company based in Delhi, India. The company works in online healthcare product retail, within the e-commerce industry. It was incorporated on 24 January 2018 (8+ years old) and is registered under CIN U74999DL2018PTC328905.
Wuze Pharmaceuticals has 2 current directors:
- Mansi Aggarwal - Director
- Praveen Kumar Singla - Director
The latest financial statements of Wuze Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Wuze Pharmaceuticals is 07AACCW1411E1ZV, registered in Delhi.
The CIN (Corporate Identification Number) of Wuze Pharmaceuticals is U74999DL2018PTC328905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wuze Pharmaceuticals was incorporated on 24 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Mansi Aggarwal ceased to be Additional Director on 29 Sep 2022. Mansi Aggarwal was appointed as Director on 01 Aug 2022. Sanchit Gupta ceased to be Additional Director on 30 Sep 2019. Wuze Pharmaceuticals has 5 board changes on record in total.
Yes, Wuze Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Wuze Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-06-0003843).
Wuze Pharmaceuticals can be reached through the website wuzeinternational.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages